J&J/Merck Mevacor Tests Include Subjects With Slightly Elevated Cholesterol

J&J/Merck is evaluating Merck's Mevacor (lovastatin) as an OTC candidate by testing the prescription cholesterol reducer in subjects with slightly elevated cholesterol levels. The company has not yet filed an application to switch Mevacor to OTC status.